Hizentra
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1020 1st Ave, King Of Prussia, Pennsylva...Website
www.hizentra.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Hizentra
CSL Behring LLC offers Hizentra, an immune globulin therapy designed to treat conditions such as Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Their services include a patient support program, in-home nurse training, financial support, and insurance navigation to ensure patients can administer their treatments confidently. The target clients are individuals diagnosed with immune deficiencies or neuropathic disorders, particularly those aged 2 and older for PI and adults for CIDP. Hizentra is marketed as a life-altering treatment, supported by patient success stories and comprehensive safety information.Explore more
Popular SearchesHizentraCSL Behring LLCSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hizentra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Hizentra has recently received funding, and reach out quickly before it becomes old news!
Hizentra, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Hizentra has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Hizentra
Check out if Hizentra is spiking on competitors!
Earning: See what the market has to say on Hizentra recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Hizentra had a recent Job posting/layoffs
Product Launch: Get notified when Hizentra launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Hizentra
Compare insights from companies similar to Hizentra, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Hizentra
$6.5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Hizentra is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hizentra is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hizentra.
Hizentra Tech Stack
A closer look at the technologies used by Hizentra
Hizentra News & Media
The European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Task Force Has Strongly Recommended Subcutaneous Immunoglobulin (SCIg) for CIDP Maintenance Treatment
KING OF PRUSSIA, Pa., Aug. 9, 2021 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Task Force has released an update to its guideline on diagnosis and treatment of Chronic...Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) To Be Covered Under Medicare Part B Effective July 18, Improving Access and Reducing Out-of-Pocket Costs for CIDP Patients
KING OF PRUSSIA, Pa., June 8, 2021 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the Centers for Medicare & Medicaid Services (CMS) has approved Hizentra for coverage under Medicare Part B for the treatment of Chronic Inflammatory Demyelinating...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hizentra
Sign Up For FreeTo access detailed company insights
CSL Behring LLC offers Hizentra, an immune globulin therapy designed to treat conditions such as Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Their services include a patient support program, in-home nurse training, financial support, and insurance navigation to ensure patients can administer their tre... Read More
